Welcome to the Sanofi Media Room

Our Media Room is designed to provide reporters with company and product news, as well as key facts, figures and background information.  To help you keep up with the latest news, we offer email alerts and RSS feeds.  If you are a reporter and have questions about the company or our products, visit the Media Contacts page.

Press Releases
Nov 17, 2020

Only biologic approved in Canada to treat severe asthma with type 2 / eosinophilic phenotype, or oral corticosteroid-dependent asthma Fourth indication for DUPIXENT® in Canada following approvals...

Sep 22, 2020

Signed agreements relate to vaccine candidate using Sanofi's recombinant protein-based technology combined with GSK's pandemic adjuvant Both companies are committed to making their COVID-19...

Aug 18, 2020

First biologic approved in Canada for adults with severe chronic rhinosinusitis with nasal polyposis (CRSwNP)1 Third indication for DUPIXENT® in Canada following moderate-to-severe atopic...

More »

Stay Updated
* Required Fields